These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26619809)

  • 21. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429.
    Singewald N; Chicchi GG; Thurner CC; Tsao KL; Spetea M; Schmidhammer H; Sreepathi HK; Ferraguti F; Singewald GM; Ebner K
    J Neurochem; 2008 Sep; 106(6):2476-88. PubMed ID: 18673452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding.
    Frokjaer VG; Vinberg M; Erritzoe D; Svarer C; Baaré W; Budtz-Joergensen E; Madsen K; Madsen J; Kessing LV; Knudsen GM
    Neuroimage; 2009 Jun; 46(2):360-6. PubMed ID: 19233297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
    Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurokinin-1 receptor deletion modulates behavioural and neurochemical alterations in an animal model of depression.
    Roche M; Kerr DM; Hunt SP; Kelly JP
    Behav Brain Res; 2012 Mar; 228(1):91-8. PubMed ID: 22155476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
    J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex.
    Guiard BP; Guilloux JP; Reperant C; Hunt SP; Toth M; Gardier AM
    Mol Pharmacol; 2007 Dec; 72(6):1411-8. PubMed ID: 17890358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental Enrichment Reduces Anxiety by Differentially Activating Serotonergic and Neuropeptide Y (NPY)-Ergic System in Indian Field Mouse (Mus booduga): An Animal Model of Post-Traumatic Stress Disorder.
    Ragu Varman D; Rajan KE
    PLoS One; 2015; 10(5):e0127945. PubMed ID: 26016844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys.
    Ichise M; Vines DC; Gura T; Anderson GM; Suomi SJ; Higley JD; Innis RB
    J Neurosci; 2006 Apr; 26(17):4638-43. PubMed ID: 16641244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study.
    Nyman M; Eskola O; Kajander J; Jokinen R; Penttinen J; Karjalainen T; Nummenmaa L; Hirvonen J; Burns D; Hargreaves R; Solin O; Hietala J
    J Affect Disord; 2019 Jan; 242():188-194. PubMed ID: 30193189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635.
    Sullivan GM; Ogden RT; Huang YY; Oquendo MA; Mann JJ; Parsey RV
    Depress Anxiety; 2013 Mar; 30(3):197-206. PubMed ID: 23408467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
    Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter - A longitudinal combined
    Mc Mahon B; Nørgaard M; Svarer C; Andersen SB; Madsen MK; Baaré WFC; Madsen J; Frokjaer VG; Knudsen GM
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1151-1160. PubMed ID: 30077433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.
    Reimold M; Smolka MN; Zimmer A; Batra A; Knobel A; Solbach C; Mundt A; Smoltczyk HU; Goldman D; Mann K; Reischl G; Machulla HJ; Bares R; Heinz A
    J Neural Transm (Vienna); 2007; 114(12):1603-9. PubMed ID: 17713719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
    Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
    Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.
    van de Giessen E; Rosell DR; Thompson JL; Xu X; Girgis RR; Ehrlich Y; Slifstein M; Abi-Dargham A; Siever LJ
    J Psychiatr Res; 2014 Nov; 58():147-54. PubMed ID: 25145808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET [11C]DASB imaging of serotonin transporters in patients with alcoholism.
    Brown AK; George DT; Fujita M; Liow JS; Ichise M; Hibbeln J; Ghose S; Sangare J; Hommer D; Innis RB
    Alcohol Clin Exp Res; 2007 Jan; 31(1):28-32. PubMed ID: 17207098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder.
    Lee HJ; Lee MS; Kang RH; Kim H; Kim SD; Kee BS; Kim YH; Kim YK; Kim JB; Yeon BK; Oh KS; Oh BH; Yoon JS; Lee C; Jung HY; Chee IS; Paik IH
    Depress Anxiety; 2005; 21(3):135-9. PubMed ID: 15965993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
    Frankle WG; Narendran R; Huang Y; Hwang DR; Lombardo I; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Jun; 57(12):1510-6. PubMed ID: 15953487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.